Lung Cancer Surgery in Turkey Trends and Forecast
The future of the lung cancer surgery market in Turkey looks promising with opportunities in the hospital, specialty cancer care center, and ambulatory surgical center markets. The global lung cancer surgery market is expected to reach an estimated $5.7 billion by 2031 with a CAGR of 3.4% from 2025 to 2031. The lung cancer surgery market in Turkey is also forecasted to witness strong growth over the forecast period. The major drivers for this market are the rising occurrence of lung cancer, the increasing consumer preference towards minimally invasive surgeries, and the growing air pollution levels.
• Lucintel forecasts that, within the product type category, surgical device is expected to witness the highest growth over the forecast period.
• Within the end use category, ambulatory surgical center is expected to witness the highest growth over the forecast period.
Emerging Trends in the Lung Cancer Surgery Market in Turkey
The lung cancer surgery environment in Turkey is changing due to increasing incidence rates, improvements in thoracic technology, and growing emphasis on personalized medicine. The healthcare system is bolstering its infrastructure to improve early detection, treatment effectiveness, and post-operative care. Turkey‘s strategic investments in minimally invasive surgery, digital platforms, and multidisciplinary care pathways are setting new standards in thoracic oncology. With public-private sector collaboration, the country is aligning surgical practice with international guidelines, making cancer care more accessible and patient-centered for wide-ranging geographic and socioeconomic groups.
• Shift Toward Genomic-Based Surgical Planning: Turkish cancer centers are increasingly employing genomic testing to inform lung cancer surgery strategies. With the identification of pivotal biomarkers, including EGFR and KRAS mutations, surgeons are able to better coordinate with oncologists to ascertain the timing and extent of resections. This movement enables optimal neoadjuvant therapy application prior to surgery and minimizes recurrence. Genomic-guided surgery is facilitating a personalized approach, guiding Turkey toward a precision oncology paradigm with improved survival and post-op results.
• Thoracic Surgery Subspecialty Training Development: Turkey is creating thoracic surgery subspecialty certifications and fellowships to train highly competent surgeons specializing in lung cancer. Teaching hospitals and universities are providing advanced programs with an emphasis on complex techniques such as VATS and robotic-assisted procedures. This is raising standards of surgery and training the next generation of thoracic specialists, particularly as cancer incidence increases and patient demand for minimally invasive treatment increases.
• Integrated Multidisciplinary Clinics Adoption: Turkish major hospitals are establishing integrated cancer clinics in which pulmonologists, thoracic surgeons, radiologists, and oncologists are working together under one roof. The multidisciplinary teams have weekly tumor boards and coordinate patient care from diagnosis to recovery. The strategy lowers the delay in treatment and ensures consistency in care plans, leading to timely and evidence-based surgical decisions. It shows the evolution of Turkey towards more comprehensive cancer care.
• Post-Surgical Telemonitoring Programs Emergence: Turkish hospitals are testing remote monitoring programs for patients undergoing lung cancer surgery through wearable technology and mobile health apps. Such platforms monitor vital signs, pain, and markers of recovery, warning clinicians of complications early on. The trend facilitates early discharge and minimizes readmission while enhancing patient satisfaction. Post-operative telemonitoring demonstrates Turkey‘s increased investment in post-surgical digital health and continuity of care.
• Prioritization of Early-Stage Detection Through Public Awareness Campaigns: To promote early diagnosis, Turkey is initiating public health campaigns that educate citizens about lung cancer symptoms and risk factors, particularly targeting smokers and workers in industries. These campaigns encourage greater participation in screening and lead to earlier-stage surgical referral. The initiative is a preventive approach aimed at moving lung cancer operations from late-stage procedures to curative ones, enhancing long-term survival rates.
The lung cancer surgery market in Turkey is being transformed through emphasis on genomic medicine, specialized education, and multidisciplinary treatment. Digital technologies and early detection initiatives are also increasing access and outcomes of treatment. These new trends reflect Turkey‘s dedication to the establishment of a contemporary, data-driven, and patient-oriented thoracic surgery environment with the ability to meet increasing demand with efficacy and accuracy.
Recent Developments in the Lung Cancer Surgery Market in Turkey
Turkey has recently taken significant steps to build a more accessible and high-quality lung cancer surgery environment. Governmental investment in oncology facilities, increased minimally invasive procedures, and evidence-based reforms are underpinning the improvement in quality of care and efficiency. These initiatives are part of the country‘s overall healthcare modernization strategy and its increasing status as a regional center for complex surgical treatment. The recent reforms are specifically aimed at advancing early-stage intervention and optimizing treatment pathways nationally.
• Establishment of Regional Oncology Centers with Thoracic Surgery Departments: The Turkish Ministry of Health has established several regional cancer hospitals with thoracic surgery departments in cities such as Erzurum and Gaziantep. These centers aim to minimize patient migration to Istanbul or Ankara by providing advanced lung cancer surgery in the local setting. They are equipped with ICU units, imaging laboratories, and qualified staff. This initiative enhances access to surgical care and decreases diagnostic and treatment delays in deprived areas.
• Introduction of National Cancer Surgery Outcome Registry: A national registry to monitor thoracic surgical outcomes, including survival, resection margin, and complication rate, has been established. Hospitals now report standardized data to enhance quality benchmarking and disclosure. The tool identifies areas of care gaps and informs decision-making for health policies. The registry is an important step towards creating a data-informed system for ongoing improvement in lung cancer surgery performance in Turkey.
• Increase in VATS and Hybrid Procedures in Public Hospitals: Public hospitals in Turkey are increasingly embracing video-assisted thoracoscopic surgery (VATS) and hybrid procedures. The minimally invasive procedures are applied for lobectomies, wedge resections, and biopsies with quicker recovery and less risk of complications. Training initiatives and upgrades in equipment are facilitating the transition. The evolution makes advanced lung cancer surgery accessible even in non-academic centers and improves surgical efficiency.
• Government-Subsidized Surgical Care under Universal Health Coverage: Surgery for lung cancer, as well as diagnostics and postoperative rehabilitation, is now completely subsidized for those who are eligible in Turkey‘s national health insurance. The scheme makes the medical procedure accessible and affordable for low-income individuals by eliminating the financial burden. Subsidization of operations by the government is encouraging equity of care for cancer and facilitating earlier and more comprehensive courses of treatment.
• International Collaborations for Surgical Research and Training: Turkish academic centers have joined forces with German, British, and Japanese institutions to conduct joint research studies and exchange surgical training. Such cooperation introduces new protocols, technology, and techniques. Surgeons get experiential exposure to international standards, propelling knowledge transfer and innovation. This advancement makes Turkey a competitive force in world thoracic surgery research.
Turkey‘s recent advances are improving its lung cancer surgery system through infrastructure development, standardized follow-up monitoring, and process modernization. With government support, international partnerships, and increased local availability of VATS and hybrid procedures, Turkey is building a more balanced and effective healthcare system. These programs are building national capability while setting the stage for international integration and long-term enhancements in lung cancer survival and quality of care.
Strategic Growth Opportunities for Lung Cancer Surgery Market in Turkey
Turkey is experiencing a rise in lung cancer incidence fueled by smoking and environmental causes. The healthcare industry is changing with enhanced access, sophisticated diagnostics, and an increasing focus on specialty care. Hospitals are adopting new surgical methods and emphasizing early diagnosis. With public and private systems becoming more modern, the main applications in lung cancer surgery are opening up growth opportunities. They encompass investments in multidisciplinary models of care, robotic systems, and training, all of which are enhancing patient outcomes and pushing the country‘s oncology scene forward.
• Growth in Minimally Invasive Surgical Techniques: Turkish medical institutions are increasingly applying video-assisted thoracoscopic surgery to lung cancer patients. The less invasive procedure means fewer complications, shorter hospital stays, and less recovery time. Training programs and access to medical equipment have facilitated its introduction in public and private hospitals. The technique is especially suited for elderly patients and early cancers. As the Ministry of Health encourages minimally invasive treatment, this is expected to open the door for wider practice, enabling more hospitals nationwide to provide high-quality, cost-saving surgical procedures.
• Rise in Use of Robotic Surgery: Turkey is investing heavily in robotic-assisted surgery, particularly in large hospitals. The equipment enables higher accuracy in complicated cases of lung cancer and has fewer post-surgical complications. Universities and teaching institutions are driving adoption with government and private sector assistance. While expensive, shared-service arrangements and leasing plans are opening up robotics to a wider audience. As more surgeons receive training, robotic surgery is increasingly becoming the norm in advanced thoracic care, making Turkey a pioneer in surgical technology innovation in the region.
• Early Detection and Screening Programs: Public health programs are increasing awareness and extending lung cancer screening with low-dose CT, particularly among high-risk groups. Early detection dramatically improves the possibility of surgical treatment. National cancer control plans optimize nationwide early intervention, lowering disease burden and enhancing survival. Hospitals gain stable surgical demand, and patients gain early treatment. These programs become increasingly accessible in provincial regions, enabling more equity in access to cancer care throughout the nation.
• Multidisciplinary Thoracic Oncology Unit Development: Turkish hospitals are organizing specialized units that integrate thoracic surgeons, oncologists, radiologists, and pulmonologists. These teams facilitate coordinated therapy, quicker diagnoses, and better planning. Integrated care pathways and enhanced outcomes benefit patients. These units also foster research, innovation, and training. With the adoption of this model by tertiary centers, smaller hospitals are encouraged to organize a similar structure with support from remote consultation. Multidisciplinary units enhance overall treatment efficiency and improve surgical success rates.
• Enhancing Surgical Training and International Cooperation: Turkey is modernizing surgeon training through partnerships with European organizations and national programs. Workshops, fellowships, and online learning platforms facilitate ongoing education. Minimally invasive procedures and robotic skill-building are priority areas. Academic hospitals are becoming centers of excellence for surgical training in the region. Improved expertise guarantees uniform surgical standards in public and private healthcare sectors. This growth in human capital supports long-term market development and enables Turkey to expand its role in regional medical tourism and global healthcare services.
Turkey‘s lung cancer surgery market is expanding with the adoption of robotic and minimally invasive technologies, early detection, and multi-disciplinary care models. Training and public health investments are building the base for quality surgical care. These thoughtful applications are enhancing survival rates and sustaining Turkey‘s regional position as a center for oncology excellence and innovation.
Lung Cancer Surgery Market in Turkey Driver and Challenges
The Turkish lung cancer surgery market is influenced by a combination of advancing healthcare reforms, technology adoption, and increasing volumes of patients. Robust public insurance cover and modernization drives are compelling hospitals to implement improved diagnostics and treatments. The system, meanwhile, is confronted with shortages of personnel, unbalanced regional access, and the costs of sophisticated equipment. Knowing these drivers and overcoming the issues is pivotal in increasing the coverage and impact of lung cancer surgical services in Turkey.
The factors responsible for driving the lung cancer surgery market in Turkey include:
• Government Commitment to Healthcare Infrastructure: Turkey‘s government keeps making extensive investments in modernizing healthcare under its City Hospitals program. These are big, integrated hospitals that have cutting-edge surgical equipment and multidisciplinary staff. The program increases access to specialized care and guarantees regular quality. They provide support for training and research and decrease wait times for procedures such as lung cancer surgery. This high public investment is a major growth driver and guarantees infrastructure preparedness as well as system scalability.
• Environmental and High Smoking Rates Risk Factors: Prevalence of smoking and air pollution exposure are key drivers for increasing incidence of lung cancer in Turkey. This fuels persistent demand for surgical and diagnostic services. Areas with industrialization and high-density urban areas have higher case volumes. Hospitals here are increasing thoracic surgery facilities and enhancing early intervention access. This driver supports the requirements for regional cancer control and heightens attention to timely surgical preparedness and case management.
• Growth of Medical Tourism in Oncology Services: Turkey is emerging as a favorite destination for foreign patients with its qualified medical staff, competitive rates, and up-to-date facilities. This influx is used to invest in high-quality surgical equipment and training for personnel. Private hospitals are enhancing levels to reach foreign patients, particularly for complex operations. Medical tourism consolidates the industry‘s cash flow base and fosters cross-border best practices. It also inspires constant innovation, facilitating fast growth in domestic market prospects in terms of surgical capabilities.
• Implementation of Sophisticated Surgical Technologies: Hospitals are embracing technologies such as robotic systems, 3D imaging, and navigation software to enhance lung cancer surgeries. These technologies enhance surgical accuracy, minimize complications, and increase recovery rates. Technological solutions also facilitate complex case management and allow for minimally invasive procedures. While costs are a challenge, public-private partnerships and leasing options are streamlining access. This driver is placing Turkey‘s surgery scene on a par with global standards.
• Public and Private Sector Cooperation: Turkey‘s blended system of healthcare facilitates collaboration between public hospitals and private practitioners. The partnerships enhance mutual access to equipment, joint development of training programs, and broader treatment coverage. Referrals are accelerated for patients, and the quality of care enhances. The collaborative models enhance efficiency, eliminate duplication, and facilitate transfer of technology between systems. Mutual cooperation ensures that a greater number of patients are treated in a timely, specialist surgical manner without regard to geographic or economic location.
Challenges in the lung cancer surgery market in Turkey are:
• Asymmetric Regional Dispersement of Surgical Facilities: Major cities like Istanbul and Ankara have concentrated healthcare resources, while rural areas face shortages of thoracic surgeons and advanced equipment. Patients often travel long distances, leading to delays and higher disease progression at diagnosis. Regional hospitals lack the same level of surgical capability and coordination. Addressing this requires infrastructure decentralization, mobile units, and teleconsultation networks. Unequal distribution limits access and affects market balance across provinces.
• Costs of Equipment and Maintenance Issues: The purchase and upkeep of robotic surgery systems, imaging equipment, and navigation technologies are costly. Public institutions operate on limited budgets, while private operators focus on the rate of return. Technology adoption is hindered by procurement delays, insufficient training, and infrastructure deficits. Smaller centers are kept outside of contemporary surgical practice without sufficient financial planning or policy intervention. This limits the spread of innovation and national advancement in advanced lung cancer surgery.
• Lack of Trained Thoracic Surgeons in Peripheral Areas: Even though teaching hospitals create highly trained practitioners, most of them like to work in large cities. This creates a shortage in rural areas where the population is increasing. People from smaller provinces get their treatment delayed because of this shortage. Training program expansion, rural incentives, and telemedicine-based supervision are critical measures to minimize this shortage. If no action is taken, the workforce gap will keep restricting surgical care accessibility across the country.
Turkey‘s market for lung cancer surgery is developing with strong public spending, private sector innovation, and increasing demand. Drivers come in the form of healthcare reforms, medical tourism, and technology. Regional disparities, labor shortages, and affordability must be addressed to allow for sustained development. Turkey can provide high-quality surgical services throughout the nation and establish itself as a regional oncology surgery leader through strategic planning.
List of Lung Cancer Surgery Market in Turkey Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies, lung cancer surgery companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the lung cancer surgery companies profiled in this report include:
• Company 1
• Company 2
• Company 3
• Company 4
• Company 5
• Company 6
• Company 7
• Company 8
• Company 9
• Company 10
Lung Cancer Surgery Market in Turkey by Segment
The study includes a forecast for the lung cancer surgery market in Turkey by product type, surgery, and end use.
Lung Cancer Surgery Market in Turkey by Product Type [Analysis by Value from 2019 to 2031]:
• Surgical Devices
• Endosurgical Equipment
• Monitoring or Visualizing Equipment
Lung Cancer Surgery Market in Turkey by Surgery [Analysis by Value from 2019 to 2031]:
• Robotic Surgery
• Thoracotomy
• Video Assisted Surgery
• Percutaneous Surgery
• Endobronchial Surgery
Lung Cancer Surgery Market in Turkey by End Use [Analysis by Value from 2019 to 2031]:
• Hospitals
• Specialty Cancer Care Centers
• Ambulatory Surgical Centers
• Others
Features of the Lung Cancer Surgery Market in Turkey
Market Size Estimates: Lung cancer surgery in Turkey market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends and forecasts by various segments.
Segmentation Analysis: Lung cancer surgery in Turkey market size by product type, surgery, and end use in terms of value ($B).
Growth Opportunities: Analysis of growth opportunities in different product type, surgery, and end use for the lung cancer surgery in Turkey.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the lung cancer surgery in Turkey.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.
FAQ
Q1. What are the major drivers influencing the growth of the lung cancer surgery market in Turkey?
Answer: The major drivers for this market are the rising occurrence of lung cancer, the increasing consumer preference towards minimally invasive surgeries, and the growing air pollution levels.
Q2. What are the major segments for lung cancer surgery market in Turkey?
Answer: The future of the lung cancer surgery market in Turkey looks promising with opportunities in the hospital, specialty cancer care center, and ambulatory surgical center markets.
Q3. Which lung cancer surgery market segment in Turkey will be the largest in future?
Answer: Lucintel forecasts that surgical device is expected to witness the highest growth over the forecast period.
Q4. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 10 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the lung cancer surgery market in Turkey by product type (surgical devices, endosurgical equipment, and monitoring or visualizing equipment), surgery (robotic surgery, thoracotomy, video assisted surgery, percutaneous surgery, and endobronchial surgery), and end use (hospitals, specialty cancer care centers, ambulatory surgical centers, and others)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.4. What are the business risks and competitive threats in this market?
Q.5. What are the emerging trends in this market and the reasons behind them?
Q.6. What are some of the changing demands of customers in the market?
Q.7. What are the new developments in the market? Which companies are leading these developments?
Q.8. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.9. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.10. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Lung Cancer Surgery Market in Turkey, Lung Cancer Surgery Market in Turkey Size, Lung Cancer Surgery Market in Turkey Growth, Lung Cancer Surgery Market in Turkey Analysis, Lung Cancer Surgery Market in Turkey Report, Lung Cancer Surgery Market in Turkey Share, Lung Cancer Surgery Market in Turkey Trends, Lung Cancer Surgery Market in Turkey Forecast, Lung Cancer Surgery Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.